These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 33831487)

  • 1. Exploring the transmucosal permeability of cyclobenzaprine: A comparative preformulation by standardized and controlled ex vivo and in vitro permeation studies.
    Majid H; Puzik A; Maier T; Eberhard D; Bartel A; Mueller HC; Burckhardt BB
    Int J Pharm; 2021 May; 601():120574. PubMed ID: 33831487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulation Development of Sublingual Cyclobenzaprine Tablets Empowered by Standardized and Physiologically Relevant Ex Vivo Permeation Studies.
    Majid H; Puzik A; Maier T; Merk R; Bartel A; Mueller HC; Burckhardt BB
    Pharmaceutics; 2021 Sep; 13(9):. PubMed ID: 34575485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development, validation and standardization of oromucosal ex-vivo permeation studies for implementation in quality-controlled environments.
    Majid H; Bartel A; Burckhardt BB
    J Pharm Biomed Anal; 2021 Feb; 194():113769. PubMed ID: 33277116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictivity of standardized and controlled permeation studies: Ex vivo - In vitro - In vivo correlation for sublingual absorption of propranolol.
    Majid H; Bartel A; Burckhardt BB
    Eur J Pharm Biopharm; 2021 Dec; 169():12-19. PubMed ID: 34508807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biopharmaceutical evaluation of surface active ophthalmic excipients using in vitro and ex vivo corneal models.
    Juretić M; Cetina-Čižmek B; Filipović-Grčić J; Hafner A; Lovrić J; Pepić I
    Eur J Pharm Sci; 2018 Jul; 120():133-141. PubMed ID: 29702232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oromucosal drug delivery: Trends in in-vitro biopharmaceutical assessment of new chemical entities and formulations.
    Brandl M; Bauer-Brandl A
    Eur J Pharm Sci; 2019 Feb; 128():112-117. PubMed ID: 30502454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral transmucosal delivery of eletriptan for neurological diseases.
    Valetti S; Riaz A; Doko A; Sultana K; Eskandari M; Prgomet Z; Feiler A; Rönn R; Dahlström B; Engblom J; Björklund S
    Int J Pharm; 2022 Nov; 627():122222. PubMed ID: 36155795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug permeability profiling using cell-free permeation tools: Overview and applications.
    Berben P; Bauer-Brandl A; Brandl M; Faller B; Flaten GE; Jacobsen AC; Brouwers J; Augustijns P
    Eur J Pharm Sci; 2018 Jul; 119():219-233. PubMed ID: 29660464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enniatin-containing solutions for oromucosal use: Quality-by-design ex-vivo transmucosal risk assessment of composition variability.
    Taevernier L; Detroyer S; Veryser L; De Spiegeleer B
    Int J Pharm; 2015 Aug; 491(1-2):144-51. PubMed ID: 26116015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skin Permeation and Antinociception of Compounded Topical Cyclobenzaprine Hydrochloride Formulations.
    Bryson E; Hartman R; Arnold J; Gorman G; Sweitzer S; Asbill S
    Int J Pharm Compd; 2015; 19(2):161-6. PubMed ID: 26685496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of the Efficacy of Transdermal Penetration Enhancers Through the Use of Human Skin and a Skin Mimic Artificial Membrane.
    Balázs B; Vizserálek G; Berkó S; Budai-Szűcs M; Kelemen A; Sinkó B; Takács-Novák K; Szabó-Révész P; Csányi E
    J Pharm Sci; 2016 Mar; 105(3):1134-40. PubMed ID: 26886318
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Pinto S; Pintado ME; Sarmento B
    Expert Opin Drug Deliv; 2020 Jan; 17(1):33-48. PubMed ID: 31786958
    [No Abstract]   [Full Text] [Related]  

  • 13. Bioenhanced sublingual tablet of drug with limited permeability using novel surfactant binder and microencapsulated polysorbate: In vitro/in vivo evaluation.
    El-Setouhy DA; Basalious EB; Abdelmalak NS
    Eur J Pharm Biopharm; 2015 Aug; 94():386-92. PubMed ID: 26086847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct estimation of the permeation of topical excipients through artificial membranes and human skin with non-invasive Terahertz time-domain techniques.
    Lopez-Dominguez V; Boix-Montañes A; Redo-Sanchez A; Tejada-Palacios J
    J Pharm Pharmacol; 2016 Jul; 68(7):873-82. PubMed ID: 27138975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and evaluation of mucoadhesive buccal dosage forms of lidocaine hydrochloride by ex-vivo permeation studies.
    Kottke D; Majid H; Breitkreutz J; Burckhardt BB
    Int J Pharm; 2020 May; 581():119293. PubMed ID: 32247812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug permeation enhancement via buccal route: possibilities and limitations.
    Senel S; Hincal AA
    J Control Release; 2001 May; 72(1-3):133-44. PubMed ID: 11389992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preformulation-Assisted Design and Characterization of Modified Release Gastroretentive Floating Extrudates Towards Improved Bioavailability and Minimized Side Effects of Baclofen.
    Ibrahim M; Naguib YW; Sarhan HA; Abdelkader H
    J Pharm Sci; 2021 Mar; 110(3):1227-1239. PubMed ID: 33069710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative estimation of drug permeation through nasal mucosa using in vitro membrane permeability across Calu-3 cell layers for predicting in vivo bioavailability after intranasal administration to rats.
    Inoue D; Furubayashi T; Tanaka A; Sakane T; Sugano K
    Eur J Pharm Biopharm; 2020 Apr; 149():145-153. PubMed ID: 32057906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transmucosal delivery of domperidone from bilayered buccal patches: in vitro, ex vivo and in vivo characterization.
    Palem CR; Gannu R; Doodipala N; Yamsani VV; Yamsani MR
    Arch Pharm Res; 2011 Oct; 34(10):1701-10. PubMed ID: 22076770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of novel amisulpride-loaded liquid self-nanoemulsifying drug delivery systems via dual tackling of its solubility and intestinal permeability.
    Gamal W; Fahmy RH; Mohamed MI
    Drug Dev Ind Pharm; 2017 Sep; 43(9):1530-1538. PubMed ID: 28447878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.